UCB SA (Belgium) Analysis
| UCB Stock | EUR 182.45 2.40 1.30% |
UCB SA is overvalued with Real Value of 138.64 and Hype Value of 184.85. The main objective of UCB SA stock analysis is to determine its intrinsic value, which is an estimate of what UCB SA is worth, separate from its market price. There are two main types of UCB SA's stock analysis: fundamental analysis and technical analysis. Fundamental analysis focuses on the financial and economic factors that affect UCB SA's performance, such as revenue growth, earnings, and financial stability. Technical analysis, on the other hand, focuses on the price and volume data of UCB SA's stock to identify patterns and trends that may indicate its future price movements.
The UCB SA stock is traded in Belgium on Euronext Brussels, with the market opening at 09:00:00 and closing at 17:30:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in Belgium. UCB SA is usually not traded on Belgian National Day, Assumption of Mary, All Saints ' Day, Christmas Day, New Year 's Day, Easter Sunday, Easter Monday, International Workers ' Day. UCB Stock trading window is adjusted to Europe/Brussels timezone.
UCB |
UCB Stock Analysis Notes
About 38.0% of the company outstanding shares are owned by insiders. The company has Price to Book (P/B) ratio of 1.55. Historically many companies with similar price-to-book (P/B) ratio do better than the market in the long run. UCB SA last dividend was issued on the 29th of April 2022. The entity had 100:1 split on the 4th of January 1999. UCB SA, a biopharmaceutical company, researches, develops, manufactures, sells, and distributes biopharmaceutical solutions for people living with neurology and immunology conditions. The company was founded in 1928 and is headquartered in Brussels, Belgium. UCB SA operates under Biotechnology classification in Belgium and is traded on Brussels Stock Exchange. It employs 6828 people. For more information please call JeanChristophe Tellier at 32 2 559 99 99 or visit https://www.ucb.com.UCB SA Investment Alerts
| About 38.0% of the company outstanding shares are owned by insiders |
UCB Market Capitalization
The company currently falls under 'Large-Cap' category with a current market capitalization of 14.84 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate UCB SA's market, we take the total number of its shares issued and multiply it by UCB SA's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.UCB Profitablity
UCB SA's profitability indicators refer to fundamental financial ratios that showcase UCB SA's ability to generate income relative to its revenue or operating costs. If, let's say, UCB SA is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, UCB SA's executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of UCB SA's profitability requires more research than a typical breakdown of UCB SA's financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
The company has Profit Margin (PM) of 0.15 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.19 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.19. Technical Drivers
As of the 28th of November, UCB SA owns the Standard Deviation of 1.71, market risk adjusted performance of 0.2837, and Mean Deviation of 1.29. Compared to fundamental indicators, the technical analysis model makes it possible for you to check helpful technical drivers of UCB SA, as well as the relationship between them. Please validate UCB SA coefficient of variation, variance, and the relationship between the downside deviation and standard deviation to decide if UCB SA is priced fairly, providing market reflects its prevailing price of 182.45 per share.UCB SA Price Movement Analysis
Incorrect Input. Please change your parameters or increase the time horizon required for running this function. The output start index for this execution was zero with a total number of output elements of zero. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. UCB SA middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for UCB SA. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.
UCB SA Outstanding Bonds
UCB SA issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. UCB SA uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most UCB bonds can be classified according to their maturity, which is the date when UCB SA has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| Boeing Co 2196 Corp BondUS097023DG73 | View | |
| HSBC Holdings PLC Corp BondUS404280DR76 | View | |
| MPLX LP 52 Corp BondUS55336VAL45 | View |
UCB SA Predictive Daily Indicators
UCB SA intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of UCB SA stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
| Accumulation Distribution | 1744.42 | |||
| Daily Balance Of Power | (0.59) | |||
| Rate Of Daily Change | 0.99 | |||
| Day Median Price | 183.2 | |||
| Day Typical Price | 182.95 | |||
| Market Facilitation Index | 1.0E-4 | |||
| Price Action Indicator | (1.95) | |||
| Period Momentum Indicator | (2.40) |
UCB SA Forecast Models
UCB SA's time-series forecasting models are one of many UCB SA's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary UCB SA's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.About UCB Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how UCB SA prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling UCB shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as UCB SA. By using and applying UCB Stock analysis, traders can create a robust methodology for identifying UCB entry and exit points for their positions.
UCB SA, a biopharmaceutical company, researches, develops, manufactures, sells, and distributes biopharmaceutical solutions for people living with neurology and immunology conditions. The company was founded in 1928 and is headquartered in Brussels, Belgium. UCB SA operates under Biotechnology classification in Belgium and is traded on Brussels Stock Exchange. It employs 6828 people.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding UCB SA to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Alpha Finder Now
Alpha FinderUse alpha and beta coefficients to find investment opportunities after accounting for the risk |
| All Next | Launch Module |
Additional Tools for UCB Stock Analysis
When running UCB SA's price analysis, check to measure UCB SA's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy UCB SA is operating at the current time. Most of UCB SA's value examination focuses on studying past and present price action to predict the probability of UCB SA's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move UCB SA's price. Additionally, you may evaluate how the addition of UCB SA to your portfolios can decrease your overall portfolio volatility.